首页> 美国卫生研究院文献>Iranian Journal of Pharmaceutical Research : IJPR >De-Esterified Tragacanth Microspheres Loaded into Eudragit S-100 Coated Capsules for Colon-Targeted Delivery
【2h】

De-Esterified Tragacanth Microspheres Loaded into Eudragit S-100 Coated Capsules for Colon-Targeted Delivery

机译:装在Eudragit S-100包衣胶囊中的去酯化黄Tra胶微球用于结肠靶向递送

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The objective of this study was to develop a novel bacterially-triggered micro-particular system of de-esterified tragacanth (DET) in combination with Eudragit S-100 coated capsules for colon drug delivery of 5-fluorouracil (5-FU) using microemulsion method. The loading study was conducted at different drug-to-polymer ratios and cross-linker concentrations. The maximum loading efficiency was achieved, 44.1% at 1:5 drug-to-polymer ratio and 0.7% cross-linker concentration. The FTIR results also confirmed the encapsulation of 5-FU in microspheres. The release profile was dependent on the cross-linker concentration, environmental pH, and presence of pectinase enzyme. Microspheres inserted into Eudragit S-100 coated capsules released less than 5% of the drug at stomach and small intestine pH levels, whereas 70% of the drug was released at colon pH levels, and about 25% of the drug did not release unless in the presence of pectinase enzyme. To omit burst release, microspheres were washed with water, and the release became pH independent, and was just achieved in the presence of pectinase enzyme. 5-FU loaded microspheres with an IC50 value of 80 µg/mL were as effective as the free drug on HT-29. Generally, the results demonstrated that drug-loaded microspheres inserted into Eudragit S-100 coated capsules can be effective for colon-targeted delivery.
机译:这项研究的目的是开发一种新型的由细菌触发的去黄tr胶(DET)与Eudragit S-100包衣胶囊结合的微触发微颗粒系统,用于通过微乳化方法将5-氟尿嘧啶(5-FU)送入结肠。负载研究是在不同的药物与聚合物的比例和交联剂浓度下进行的。达到最大负载效率,药物与聚合物的比例为1:5时为44.1%,交联剂浓度为0.7%。 FTIR结果也证实了5-FU在微球中的包封。释放曲线取决于交联剂浓度,环境pH和果胶酶的存在。插入Eudragit S-100涂层胶囊的微球在胃和小肠的pH值下释放的药物少于5%,而在结肠pH值的药物中释放的药物的占70%,除非在结肠中pH的药物释放约25%。果胶酶的存在。为了省略突然释放,用水洗涤微球,并且释放变得与pH无关,并且仅在果胶酶的存在下实现。 IC50值为80 µg / mL的装有5-FU的微球与HT-29上的游离药物一样有效。通常,结果表明,插入Eudragit S-100包衣胶囊的载药微球可以有效地靶向结肠。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号